Answers are grounded in this paper and cite their sources.
A chemical study on Chenopodium quinoa Willd. bran identified four new triterpene saponins ( 1 – 4 ) and 12 known analogues ( 5 – 16 ). The structures were determined through extensive spectroscopic analysis. Compounds 1 and 2 were identified as rare dodecandralol triterpenoid saponins, marking their first discovery in C. quinoa . Compounds 1 – 16 were evaluated for α-glucosidase inhibitory activity, with queretaroic acid 28- O -β- d -glucopyranosyl ester (QA, IC 50 = 42.3 ± 4.1 μM) showing potent inhibitory activity in a mixed-type manner. Surface plasmon resonance (SPR) and Fourier transform infrared (FT-IR) assays confirmed QA’s strong binding affinity to α-glucosidase. Molecular docking and dynamics simulations revealed QA interacts with the enzyme primarily via hydrogen bonding and hydrophobic contacts, resulting in conformational changes and inhibition activity of α-glucosidase. Additionally, QA strongly suppressed postprandial hyperglycemia in diabetes mellitus (DM) mice in vivo. These findings establish C. quinoa bran as a source of quinoa saponins with potential for hypoglycemic drug development.
No takes yet. Share an insight, caveat, or question.
Cao et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: